Byron C Hann (Byron Hann)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Venues

Science signaling

The Journal of experimental medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical transplantation

UCSF Medical Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

UCSF Medical Center Sep 01 1985 - Jun 15 1994

United States

PHD :: Biochemistry

Publications

Honglin Jiang, Ryan K Muir, Ryan L Gonciarz, Adam B Olshen, Iwei Yeh, Byron C Hann, Ning Zhao, Yung-Hua Wang, Spencer C Behr, James E Korkola, Kenneth W Bayles, Eric A Collisson, Adam R Renslo
Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors. The Journal of experimental medicine 219 (4) (2022)
Daniel W Sherbenou, Yang Su, Christopher R Behrens, Blake T Aftab, Olivia Perez de Acha, Megan Murnane, Shelby C Bearrows, Byron C Hann, Jeffery L Wolf, Thomas G Martin, Bin Liu
Potent Activity of an Anti-ICAM1 Antibody-Drug Conjugate against Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)
Efrat T Harel, Jun Shoji, Vivek Abraham, Loan Miller, Zoltan G Laszik, Tine Thurison, Andrew J King, Adam B Olshen, Joey Leung, Gyula Szabo, Byron C Hann, Gunilla Høyer-Hansen, Charles S Craik, Flavio G Vincenti
Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation. Clinical transplantation 33 (3) (2019)
Gary K Scott, Christina Yau, Beatrice C Becker, Sana Khateeb, Sophia Mahoney, Martin Borch Jensen, Byron C Hann, Bryan J Cowen, Scott D Pegan, Christopher C Benz
Targeting Mitochondrial Proline Dehydrogenase with a Suicide Inhibitor to Exploit Synthetic Lethal Interactions with p53 Upregulation and Glutaminase Inhibition. Molecular cancer therapeutics 18 (8) (2019)
Hao G Nguyen, Crystal S Conn, Yae Kye, Lingru Xue, Craig M Forester, Janet E Cowan, Andrew C Hsieh, John T Cunningham, Charles Truillet, Feven Tameire, Kenneth W Bayles, Christopher P Evans, Joy C Yang, Byron C Hann, Constantinos Koumenis, Peter Walter, Peter R Carroll, Davide Ruggero
Development of a stress response therapy targeting aggressive prostate cancer. Science translational medicine 10 (439) (2019)
Kevin Lou, Veronica Steri, Alex Y Ge, Y Christina Hwang, Christopher H Yogodzinski, Arielle R Shkedi, Alex L M Choi, Dominique C Mitchell, Danielle L Swaney, Byron C Hann, John D Gordan, Kevan M Shokat, Luke A Gilbert
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies. Science signaling 12 (583) (2019)

Byron C Hann.css-eqlu8i{font-size:small;padding-left:4px;} (Byron Hann)

Publication Activity (10 Years)

Top Topics

Top Venues

Byron C Hann (Byron Hann)